Related Experiment Videos
Disseminated intravascular coagulation. Objective criteria for diagnosis and management
1Department of Oncology and Hematology, Presbyterian Hospital of Dallas, Texas.
Insights
Disseminated intravascular coagulation (DIC) involves complex hemostasis system interactions. This review clarifies diagnosis and management, offering objective criteria for severity and treatment response, aiding clinical decisions.
Area of Science:
- Hematology
- Pathophysiology
- Clinical Medicine
Background:
- Disseminated intravascular coagulation (DIC) presents complex clinical and laboratory findings due to intricate hemostasis system interrelationships.
- Understanding these pathophysiological connections is crucial for accurate diagnosis and effective management of both fulminant and low-grade DIC.
Purpose of the Study:
- To present current concepts on the cause, pathophysiology, diagnosis, and management of DIC.
- To delineate objective clinical and laboratory criteria for DIC diagnosis, reducing confusion and empirical decision-making.
- To provide guidelines for assessing DIC severity, response to therapy, and criteria for discontinuing treatment.
Main Methods:
- Comprehensive review of current concepts and literature on DIC.
- Emphasis on the interrelationships within the hemostasis system.
- Delineation of objective diagnostic and therapeutic criteria.
Main Results:
- Objective criteria for diagnosing DIC have been established, aiming to minimize diagnostic ambiguity.
- Guidelines for assessing DIC severity and response to therapy are presented.
- Criteria for discontinuing therapy when continuation is likely fruitless are provided.
Conclusions:
- Clear understanding of pathophysiological interrelationships is key to managing DIC.
- Individualized therapy is essential, considering patient-specific factors and DIC characteristics.
- Many organ-specific syndromes share pathophysiology with DIC but are recognized as distinct entities.
Abstract:
Current concepts of the cause, pathophysiology, clinical and laboratory diagnosis, and management of fulminant and low-grade DIC have been presented. Considerable attention has been devoted to interrelationships within the hemostasis system. Only by clearly understanding these pathophysiological interrelationships can the clinician and laboratory scientist appreciate the divergent and wide spectrum of often confusing clinical and laboratory findings in patients with DIC. In this discussion, objective clinical and laboratory criteria for a diagnosis of DIC have been delineated, thus eradicating unnecessary confusion and empirical decisions regarding the diagnosis. Many therapeutic decisions to be made are controversial and will remain so until more is published about specific therapeutic modalities and survival patterns. Also, therapy must be highly individualized depending on the nature of DIC, age, cause of DIC, site and severity of hemorrhage or thrombosis, and hemodynamic and other clinical parameters. Also presented are clear criteria for severity of DIC and objective criteria for defining a response to therapy. Also, because it is often difficult for the individual physician to decide when to stop often extensive therapy, objective criteria whereby therapy may be stopped, as continuation is likely fruitless, have been presented as a guideline. Lastly, it should be appreciated that many syndromes that are often organ specific share common pathophysiology with DIC but are typically identified as an independent disease entity, such as hemolytic uremic syndrome, adult shock lung syndrome, eclampsia, and many other isolated organ-specific disorders.